Parnell Pharmaceuticals Holdings Price to Sales Ratio 2014-2018 | PARNF
Historical PS ratio values for Parnell Pharmaceuticals Holdings (PARNF) over the last 10 years. The current P/S ratio for Parnell Pharmaceuticals Holdings as of June 05, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Parnell Pharmaceuticals Holdings P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-04-22 |
0.08 |
|
0.39 |
| 2018-06-30 |
0.18 |
$0.20 |
0.88 |
| 2018-03-31 |
0.30 |
$0.48 |
0.63 |
| 2017-12-31 |
0.60 |
$0.73 |
0.82 |
| 2016-12-31 |
0.69 |
$0.92 |
0.75 |
| 2016-09-30 |
1.42 |
$0.92 |
1.54 |
| 2015-12-31 |
3.88 |
$0.74 |
5.21 |
| 2015-09-30 |
3.44 |
$0.74 |
4.66 |
| 2015-06-30 |
4.95 |
$0.60 |
8.23 |
| 2015-03-31 |
4.91 |
$0.39 |
12.46 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
